Medical illustration

Activity content starts in:

Industry Webcast

Treating MDD: A Rapid-Acting Oral Antidepressant With Multimodal ActivityIndustry Webcast Sponsored by Axsome Therapeutics, Inc.; Not for CME/CE Credit

This product theater will highlight the current unmet needs in MDD and present a treatment option with rapid symptom improvement for adult patients with MDD.

Register

CME/CE Information

0 Credits - Not for CME/CE Credit

Release Date: 1/14/2025

Expiration Date: 1/14/2025

Topics

Faculty

Heather Luing, MD

Florida Center for TMS
Chief Medical Officer
University of Florida at Flagler Hospital
Attending Psychiatrist

Learn More

Supporters and Partners

Industry Sponsor

Axsome Therapeutics, Inc.

Fine Print

The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.

Treating MDD: A Rapid-Acting Oral Antidepressant With Multimodal Activity

Register